Can artificial intelligence be the future solution to the enormous challenges and suffering caused by Schizophrenia?
Open Access
- 28 February 2025
- journal article
- review article
- Published by Springer Nature in Schizophrenia
- Vol. 11 (1) , 1-16
Abstract
This study evaluated the potential of artificial intelligence (AI) in the diagnosis, treatment, and prognostic assessment of schizophrenia (SZ) and explored collaborative directions for AI applications in future medical innovations. SZ is a severe mental disorder that causes significant suffering and imposes challenges on patients. With the rapid advancement of machine learning and deep learning technologies, AI has demonstrated notable advantages in the early diagnosis of high-risk populations. By integrating multidimensional biomarkers and linguistic behavior data of patients, AI can provide further objective and precise diagnostic criteria. Moreover, it aids in formulating personalized treatment plans, enhancing therapeutic outcomes, and offering new therapeutic strategies for patients with treatment-resistant SZ. Furthermore, AI excels in developing individualized prognostic plans, which enables the rapid identification of disease progression, accurate prediction of disease trajectory, and timely adjustment of treatment strategies, thereby improving prognosis and facilitating recovery. Despite the immense potential of AI in SZ management, its role as an auxiliary tool must be emphasized, with clinical judgment and compassionate care from healthcare professionals remaining crucial. Future research should focus on optimizing human–machine interactions to achieve efficient AI application in SZ management. The in-depth integration of AI technology into clinical practice will advance the field of SZ, ultimately improving the quality of life and treatment outcomes of patients.Keywords
This publication has 104 references indexed in Scilit:
- Multisite prediction of 4-week and 52-week treatment outcomes in patients with first-episode psychosis: a machine learning approachThe Lancet Psychiatry, 2016
- Thought-Controlled Nanoscale Robots in a Living HostPLOS ONE, 2016
- Estimating the true global burden of mental illnessThe Lancet Psychiatry, 2016
- Sharing the wealth: Neuroimaging data repositoriesNeuroImage, 2016
- De novo variants in sporadic cases of childhood onset schizophreniaEuropean Journal of Human Genetics, 2015
- A new framework to enhance the interpretation of external validation studies of clinical prediction modelsJournal of Clinical Epidemiology, 2015
- Can structural MRI aid in clinical classification? A machine learning study in two independent samples of patients with schizophrenia, bipolar disorder and healthy subjectsNeuroImage, 2014
- Using Support Vector Machine to identify imaging biomarkers of neurological and psychiatric disease: A critical reviewNeuroscience & Biobehavioral Reviews, 2012
- A pilot study to determine whether machine learning methodologies using pre-treatment electroencephalography can predict the symptomatic response to clozapine therapyClinical Neurophysiology, 2010
- Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statementInternational Journal of Surgery, 2010